Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis

ConclusionThese results suggest that apremilast prolongs the time to first biologic therapy use in patients with psoriasis, thereby reducing the total medical cost and decreasing the economic burden on patients.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research